Silk Road Medical Inc. (SILK) Tops Q2 EPS by 5c

Silk Road Medical Inc. (NASDAQ: SILK) reported Q2 EPS of ($0.31), $0.05 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $26.5 million versus the consensus estimate of $25.34 million.

GUIDANCE:

Silk Road Medical Inc. sees Q3 2021 revenue of $104-109 million, versus the consensus of $106.04 million.

For earnings history and earnings-related data on Silk Road Medical Inc. (SILK) click here.

You May Also Be Interested In

• ATN International (ATNI) Misses Q1 EPS by 46c ; Offers Guidance
• First Bancshares (FBMS) Tops Q1 EPS by 6c
• CVB Financial (CVBF) Tops Q1 EPS by 1c